CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −453 | $93.90 | $43K | 3,202 |
| 2018-09-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −1,229 | $94.75 | $116K | 1,973 |
| 2018-09-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −602 | $95.84 | $58K | 1,371 |
| 2018-09-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −1,371 | $96.89 | $133K | 0 |
| 2018-09-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,955 | 72,270 | ||
| 2018-08-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion | +2,955 | $43.46 | $128K | 4,465 |
| 2018-08-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −572 | $90.58 | $52K | 3,893 |
| 2018-08-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −700 | $91.49 | $64K | 3,193 |
| 2018-08-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −2,224 | $92.68 | $206K | 969 |
| 2018-08-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −659 | $93.49 | $62K | 310 |
| 2018-08-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,955 | 75,225 | ||
| 2018-07-27 | Luly Jay R. President and CEO | Exercise or conversion | +8,498 | $11.77 | $100K | 601,524 |
| 2018-07-27 | Luly Jay R. President and CEO | Exercise or conversion · Stock Option (right to buy) | −8,498 | 0 | ||
| 2018-07-18 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −1,185 | $123.72 | $147K | 5,370 |
| 2018-07-18 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −445 | $124.20 | $55K | 4,925 |
| 2018-07-18 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −1,621 | $125.60 | $204K | 3,304 |
| 2018-07-18 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −904 | $126.40 | $114K | 2,400 |
| 2018-07-18 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion | +2,955 | $43.46 | $128K | 6,555 |
| 2018-07-18 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −2,075 | $123.72 | $257K | 4,480 |
| 2018-07-18 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −445 | $124.20 | $55K | 4,035 |
Page 27 of 31 · 619 trades